H-L-beta-HGlu-OH*HCl

H-L-beta-HGlu-OH*HCl is the hydrochloride salt of an L-configured beta-homologated glutamic acid derivative, presenting a chiral amino acid framework with a side-chain carboxylic acid that can be used for controlled ionic interactions and subsequent functional-group transformations. The molecule contains a free primary amino group and a free carboxylic acid at the alpha position, together with an additional carboxyl functionality on the beta-homologated side chain, enabling orthogonal derivatization and peptide coupling logic. Salt formation with HCl improves handling of the basic amino site while maintaining the acid groups as reactive handles for activation, esterification, or amide bond formation. The stereodefined amino acid skeleton and the presence of multiple carboxyl groups make it suitable as a chiral building block and biochemical research intermediate for constructing peptide analogs and charged peptidomimetic scaffolds.

1. Peptide Synthesis

H-L-beta-HGlu-OH*HCl is applied in peptide synthesis as a charged amino acid building block where the L-configuration and beta-homologated side-chain carboxyl group influence coupling outcomes and downstream conformational preferences. The free amino group can be protected to form an N-protected amino acid derivative, while the carboxylic acids can be selectively activated or temporarily masked to achieve chemoselective peptide bond formation. Salt-stabilized handling supports integration into protected amino acid workflows that rely on standard coupling chemistries followed by deprotection to regenerate the functional side-chain carboxyl. Incorporation of this beta-homologated glutamate motif can be used to prepare peptide sequences and peptide analogs designed to probe how altered side-chain length and charge distribution affect structure and recognition.

2. Amino Acid Derivatization

H-L-beta-HGlu-OH*HCl serves as a substrate for amino acid derivatization in synthetic organic chemistry and biochemical reagent development, leveraging its multiple carboxyl groups and stereodefined chiral center. The alpha-amino functionality enables formation of amides, ureas, or carbamates after appropriate protection, while the side-chain carboxylic acid can be converted to esters, amides, or activated intermediates for subsequent coupling. Controlled protection-group strategies such as orthogonal esterification or selective carboxyl masking can support stepwise synthesis of mono-functionalized derivatives rather than mixtures of over-modified products. Downstream derivatives prepared from this amino acid can function as intermediates for peptidomimetic construction, charged ligands, and process-ready building blocks for fine chemical synthesis.

3. Bioconjugation Chemistry

H-L-beta-HGlu-OH*HCl is used in bioconjugation chemistry to introduce a stereodefined, carboxyl-rich amino acid handle that can support linker installation and controlled conjugate formation. The side-chain carboxylic acid provides a functional group for activation to amide or ester linkages, while the alpha carboxyl group can be managed through protection or activation depending on whether the conjugation target requires mono- or di-functional attachment. HCl salt formation helps stabilize the amino site during intermediate handling, which can be relevant when preparing N-protected derivatives for controlled coupling to biomolecule scaffolds. Resulting conjugation-ready amino acid derivatives can be employed to generate labeled peptides, charged affinity tags, or biomolecule-modified constructs used in chemical biology workflows.

4. Enzyme Studies

H-L-beta-HGlu-OH*HCl can be incorporated into enzyme studies as a chiral amino acid analog for probing substrate recognition, catalytic tolerance, and active-site charge requirements. The beta-homologated glutamate architecture presents a distinct spatial arrangement of carboxylate groups relative to canonical glutamate, which can alter binding geometry in enzymes that process acidic amino acid residues or glutamate-containing motifs. Protection-group strategies that allow selective presentation of the side-chain carboxylate can enable preparation of peptide substrates or inhibitors that mimic charged interactions while maintaining stereochemical fidelity. Such constructs can support mechanistic investigations and structure-function studies in biochemical research and applied enzyme characterization.

5. Pharmaceutical Intermediate Preparation

H-L-beta-HGlu-OH*HCl is suitable for pharmaceutical intermediate preparation where amino acid-derived, multi-carboxyl chiral intermediates are used to build polar fragments and peptidomimetic scaffolds. The presence of an L-configured amino acid backbone with a beta-homologated side-chain carboxyl group enables downstream formation of N-protected intermediates, activated esters, and amide-forming derivatives that integrate into medicinal chemistry synthesis routes. Salt handling can support consistent processing during stepwise protection, activation, and coupling sequences that require reproducible stereochemical integrity. Prepared derivatives can serve as intermediates for generating charged heteroatom-rich molecules used in SAR studies and medicinal chemistry exploration, including peptide-like structures and constrained analogs.

6. Process Chemistry Intermediate

H-L-beta-HGlu-OH*HCl is applied as a process chemistry intermediate for industrial fine chemical synthesis where controlled functional-group management is required for scale-up-friendly operations. The hydrochloride salt form provides a practical starting point for managing the basic amino site during protection, while the multiple carboxylic acids enable predictable activation and selective masking strategies in manufacturing workflows. Beta-homologated glutamate functionality can be translated into downstream intermediates such as mono-protected amino acids, esterified carboxylates, or activated coupling partners used to construct larger molecules. Use in process routes supports preparation of chiral amino acid derivatives and peptide building blocks that feed into specialty chemical production and applied synthetic manufacturing of polar, carboxylate-bearing compounds.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

3. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists